vs
ALPHA & OMEGA SEMICONDUCTOR Ltd（AOSL）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是ALPHA & OMEGA SEMICONDUCTOR Ltd的1.3倍（$207.3M vs $162.3M），ALPHA & OMEGA SEMICONDUCTOR Ltd净利率更高（-8.2% vs -62.0%，领先53.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -6.3%），ALPHA & OMEGA SEMICONDUCTOR Ltd自由现金流更多（$-23.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 4.0%）
Alpha & Omega Semiconductor是一家专业功率半导体供应商，主营功率MOSFET、IGBT、模拟芯片及电源管理模块的研发、生产与销售，产品广泛应用于消费电子、工业设备、汽车、通信和计算等领域，业务覆盖全球主要市场。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
AOSL vs RARE — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $162.3M | $207.3M |
| 净利润 | $-13.3M | $-128.6M |
| 毛利率 | 21.5% | — |
| 营业利润率 | -8.4% | -54.7% |
| 净利率 | -8.2% | -62.0% |
| 营收同比 | -6.3% | 25.9% |
| 净利润同比 | -101.0% | 3.5% |
| 每股收益（稀释后） | $-0.45 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $162.3M | $207.3M | ||
| Q3 25 | $182.5M | $159.9M | ||
| Q2 25 | $176.5M | $166.5M | ||
| Q1 25 | $164.6M | $139.3M | ||
| Q4 24 | $173.2M | $164.6M | ||
| Q3 24 | $181.9M | $139.5M | ||
| Q2 24 | $161.3M | $147.0M | ||
| Q1 24 | $150.1M | $108.8M |
| Q4 25 | $-13.3M | $-128.6M | ||
| Q3 25 | $-2.1M | $-180.4M | ||
| Q2 25 | $-77.1M | $-115.0M | ||
| Q1 25 | $-10.8M | $-151.1M | ||
| Q4 24 | $-6.6M | $-133.2M | ||
| Q3 24 | $-2.5M | $-133.5M | ||
| Q2 24 | $-2.7M | $-131.6M | ||
| Q1 24 | $-11.2M | $-170.7M |
| Q4 25 | 21.5% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | 21.4% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 25.7% | — | ||
| Q1 24 | 23.7% | — |
| Q4 25 | -8.4% | -54.7% | ||
| Q3 25 | -2.5% | -106.9% | ||
| Q2 25 | -6.6% | -64.8% | ||
| Q1 25 | -6.5% | -102.6% | ||
| Q4 24 | -3.4% | -74.3% | ||
| Q3 24 | -0.1% | -94.6% | ||
| Q2 24 | -0.9% | -79.1% | ||
| Q1 24 | -7.0% | -151.9% |
| Q4 25 | -8.2% | -62.0% | ||
| Q3 25 | -1.2% | -112.8% | ||
| Q2 25 | -43.7% | -69.0% | ||
| Q1 25 | -6.6% | -108.5% | ||
| Q4 24 | -3.8% | -80.9% | ||
| Q3 24 | -1.4% | -95.7% | ||
| Q2 24 | -1.7% | -89.5% | ||
| Q1 24 | -7.5% | -156.8% |
| Q4 25 | $-0.45 | $-1.28 | ||
| Q3 25 | $-0.07 | $-1.81 | ||
| Q2 25 | $-2.61 | $-1.17 | ||
| Q1 25 | $-0.37 | $-1.57 | ||
| Q4 24 | $-0.23 | $-1.34 | ||
| Q3 24 | $-0.09 | $-1.40 | ||
| Q2 24 | $-0.09 | $-1.52 | ||
| Q1 24 | $-0.39 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.3M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $818.8M | $-80.0M |
| 总资产 | $1.0B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $196.3M | $421.0M | ||
| Q3 25 | $223.5M | $202.5M | ||
| Q2 25 | $153.1M | $176.3M | ||
| Q1 25 | $169.4M | $127.1M | ||
| Q4 24 | $182.6M | $174.0M | ||
| Q3 24 | $176.0M | $150.6M | ||
| Q2 24 | $175.1M | $480.7M | ||
| Q1 24 | $174.4M | $112.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $14.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $26.7M | — | ||
| Q1 24 | — | — |
| Q4 25 | $818.8M | $-80.0M | ||
| Q3 25 | $834.1M | $9.2M | ||
| Q2 25 | $822.3M | $151.3M | ||
| Q1 25 | $886.3M | $144.2M | ||
| Q4 24 | $902.6M | $255.0M | ||
| Q3 24 | $895.3M | $346.8M | ||
| Q2 24 | $891.6M | $432.4M | ||
| Q1 24 | $888.9M | $140.3M |
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.1B | $1.5B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | $1.1B | $1.6B | ||
| Q1 24 | $1.2B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | -14.2% | -48.6% |
| 资本支出强度资本支出/营收 | 9.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-8.1M | $-99.8M | ||
| Q3 25 | $10.2M | $-91.4M | ||
| Q2 25 | $-2.8M | $-108.3M | ||
| Q1 25 | $7.4M | $-166.5M | ||
| Q4 24 | $14.1M | $-79.3M | ||
| Q3 24 | $11.0M | $-67.0M | ||
| Q2 24 | $7.1M | $-77.0M | ||
| Q1 24 | $28.2M | $-190.7M |
| Q4 25 | $-23.1M | $-100.8M | ||
| Q3 25 | $420.0K | $-92.7M | ||
| Q2 25 | $-17.2M | $-110.7M | ||
| Q1 25 | $-1.1M | $-167.8M | ||
| Q4 24 | $6.6M | $-79.5M | ||
| Q3 24 | $4.1M | $-68.6M | ||
| Q2 24 | $-210.0K | $-79.0M | ||
| Q1 24 | $20.5M | $-193.9M |
| Q4 25 | -14.2% | -48.6% | ||
| Q3 25 | 0.2% | -58.0% | ||
| Q2 25 | -9.7% | -66.5% | ||
| Q1 25 | -0.6% | -120.5% | ||
| Q4 24 | 3.8% | -48.3% | ||
| Q3 24 | 2.3% | -49.2% | ||
| Q2 24 | -0.1% | -53.7% | ||
| Q1 24 | 13.7% | -178.2% |
| Q4 25 | 9.2% | 0.5% | ||
| Q3 25 | 5.4% | 0.8% | ||
| Q2 25 | 8.1% | 1.5% | ||
| Q1 25 | 5.1% | 1.0% | ||
| Q4 24 | 4.3% | 0.1% | ||
| Q3 24 | 3.8% | 1.2% | ||
| Q2 24 | 4.5% | 1.4% | ||
| Q1 24 | 5.2% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AOSL
| Power Discrete | $101.0M | 62% |
| Power Ic | $58.8M | 36% |
| Packaging And Testing Services | $2.5M | 2% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
